Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Empagliflozin 25mg / Linagliptin 5mg tablets
0601023AYAAABAB
|
Empagliflozin/linagliptin | Empagliflozin/linagliptin | Endocrine System | 1,356 |
|
Empagliflozin 10mg / Linagliptin 5mg tablets
0601023AYAAAAAA
|
Empagliflozin/linagliptin | Empagliflozin/linagliptin | Endocrine System | 868 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.